Navigating Advances in IgA Nephropathy: Key Developments for Therapies Targeting the B-Cell Pathway

Navigating Advances in IgA Nephropathy: Key Developments for Therapies Targeting the B-Cell Pathway

Published on Dec 31
31:11
Keeping Current CME
0:00
0:00
<p>Experts decode American Society of Nephrology (ASN) 2025 immunoglobulin A (IgA) nephropathy trials: B‑cell therapies, who benefits, and practical steps to improve patient care.</p> <p>Credit available for this activity expires: 12/24/2026<br /> Earn Credit / Learning Objectives & Disclosures: <a href= "https://www.medscape.org/viewarticle/navigating-advances-iga-nephropathy-key-developments-2025a100105j?ecd=bdc_podcast_libsyn_mscpedu" target="_blank" rel= "noopener">https://www.medscape.org/viewarticle/navigating-advances-iga-nephropathy-key-developments-2025a100105j?ecd=bdc_podcast_libsyn_mscpedu</a></p>